Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?

Raymond N. DuBois

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2691-2693
Number of pages3
JournalJournal of Clinical Oncology
Volume24
Issue number18
DOIs
StatePublished - Jun 20 2006
Externally publishedYes

Fingerprint

Local Neoplasm Recurrences
Pyrazoles
Cyclooxygenase 2 Inhibitors
Sulfonamides
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cyclooxygenase-2 selective inhibitors and prostate cancer : What is the clinical benefit? / DuBois, Raymond N.

In: Journal of Clinical Oncology, Vol. 24, No. 18, 20.06.2006, p. 2691-2693.

Research output: Contribution to journalArticle

@article{520f85d641e6473fb516c0db44ee72a1,
title = "Cyclooxygenase-2 selective inhibitors and prostate cancer: What is the clinical benefit?",
author = "DuBois, {Raymond N.}",
year = "2006",
month = "6",
day = "20",
doi = "10.1200/JCO.2006.05.9709",
language = "English (US)",
volume = "24",
pages = "2691--2693",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "18",

}

TY - JOUR

T1 - Cyclooxygenase-2 selective inhibitors and prostate cancer

T2 - What is the clinical benefit?

AU - DuBois, Raymond N.

PY - 2006/6/20

Y1 - 2006/6/20

UR - http://www.scopus.com/inward/record.url?scp=33745578642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745578642&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.05.9709

DO - 10.1200/JCO.2006.05.9709

M3 - Article

C2 - 16782907

AN - SCOPUS:33745578642

VL - 24

SP - 2691

EP - 2693

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 18

ER -